|
Pressure BioSciences, Inc. |
|
|
14 Norfolk Ave.
South Easton, MA 02375 USA
phone:508-230-1828
fax:508-230-1829
|
|
| Symbol |
PBIO |
| Exchange |
Nasdaq |
| Founded |
1978 |
| Employees |
13 |
|
|
| www.pressurebiosciences.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Focuses on the development and commercialization of a platform technology called pressure cycling technology. |
|
| Management |
| Richard T. Schumacher, CEO & Founder; Dr. Edmund Ting - Senior Vice President of Engineering; Dr. Nathan P. Lawrence, Ph.D - Vice President of Marketing; Dr. Alexander Lazarev, Ph.D. - Vice President of Research and Development; Mr. Matthew Potter, Vice President of Sales |
| |
|
|
|
|
|
|
|
| Keywords |
| Sample-preparation, cell-and-tissue-lysis, biomolecule-extraction, sample-processing, proteomics, genomics, metabolomics, lipidomics, transcriptomics, nucleic-acids, DNA, RNA, proteins, lipids, small-molecules, mass-spectrometry, PBIO |
|
|
|
| Description |
|
Pressure Cycling Technology (PCT) uses rapid
cycles of hydrostatic pressure between ambient and ultra high levels to control biomolecular interactions, allowing for a high degree of precision, reproducibility, convenience, speed, and safety. This unique,
patented technology offers the potential for broad applications in a number of established and
emerging fields, including genomics, proteomics,
drug discovery & development, process purification, pathogen inactivation, immunodiagnostics, and
DNA sequencing. |
|
| Products / Services |
PBI focuses on the development and sale of PCT-enhanced enzymatic digestion products designed specifically for the mass spectrometry marketplace, as well as sample preparation products for biomarker discovery, soil and plant biology, forensics, histology, and counter-bioterror applications.
|
|
| Technology / Differentiation |
PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (up to 35,000 psi and greater) to control bio-molecular interactions.
PBI currently holds 13 US and 4 foreign patents covering multiple applications of PCT in the life sciences field, including in such areas as genomic and proteomic sample preparation, pathogen inactivation, control of enzymes, immunodiagnostics, and protein purification. |
|
| Market / Customers |
PBI serves academic laboratories; government agencies; and biotechnology, pharmaceutical, and life science companies.
|
|
| Competitors / Substitutes / Alternatives |
Agilent Technologies Inc., BD Biosciences (privately held), Thermo Fisher Scientific, Inc.
|
|
| Strategy |
"We have a sharp, strategic focus that we believe gives us a realistic opportunity to successfully reach our short and long-term business goals, which include:
A significant increase in the installed base of PCT Sample Preparation Systems
Consistent revenue growth
A significant strategic alliance with one or more marketing/distribution partners by the end of 2009.
Strong, growing presence in the mass spectrometry, PCT-enhanced enzymology applications, biomarker discovery, soil and plant biology, forensics, histology, and the counter-bioterror markets
Continued market acceptance of PCT through the publication and presentation of independent data by scientific leaders who are both collaborators and customers
Increased shareholder value profitability
Although we expect to maintain a sharpened focus on our short and long-term business goals going forward, we believe that our strong IP and proprietary positions in other areas, such as the potential of using enhanced enzymatic reactions in the area of bio-fuel development, using PCT for the inactivation of pathogens, and using PCT in other important areas of sample preparation, lend themselves well for licensing possibilities. We plan to pursue this avenue during 2009."
|
|
| Funding |
| PBI currently holds 13 US and 6 foreign patents covering multiple applications of PCT in the life sciences field, including genomic and proteomic sample preparation, pathogen inactivation, the control of chemical (primarily enzymatic) reactions, immunodiagnostics, and protein purification. |
|
| Status |
| - |
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members